{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T18:00:08Z","timestamp":1790964008488,"version":"4.1.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2018,10,8]],"date-time":"2018-10-08T00:00:00Z","timestamp":1538956800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Chem Biol"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1038\/s41589-018-0136-y","type":"journal-article","created":{"date-parts":[[2018,10,8]],"date-time":"2018-10-08T08:54:26Z","timestamp":1538988866000},"page":"1032-1042","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["MCT2 mediates concentration-dependent inhibition of glutamine metabolism by MOG"],"prefix":"10.1038","volume":"14","author":[{"given":"Louise","family":"Fets","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul C.","family":"Driscoll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona","family":"Grimm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aakriti","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patr\u00edcia M.","family":"Nunes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michalis","family":"Gounis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ginevra","family":"Doglioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Papageorgiou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy J.","family":"Ragan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastien","family":"Campos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana","family":"Silva dos Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James I.","family":"MacRae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"O\u2019Reilly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan J.","family":"Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cyril H.","family":"Benes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin D.","family":"Courtney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"House","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios","family":"Anastasiou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,10,8]]},"reference":[{"key":"136_CR1","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.15252\/embj.201696151","volume":"36","author":"J Zhang","year":"2017","unstructured":"Zhang, J., Pavlova, N. N. & Thompson, C. B. Cancer cell metabolism: the essential role of the nonessential amino acid, glutamine. EMBO J. 36, 1302\u20131315 (2017).","journal-title":"EMBO J."},{"key":"136_CR2","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1038\/nrc.2016.71","volume":"16","author":"BJ Altman","year":"2016","unstructured":"Altman, B. J., Stine, Z. E. & Dang, C. V. From Krebs to clinic: glutamine metabolism to cancer therapy. Nat. Rev. Cancer 16, 619\u2013634 (2016).","journal-title":"Nat. Rev. Cancer"},{"key":"136_CR3","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1038\/bjc.2017.113","volume":"116","author":"ER Still","year":"2017","unstructured":"Still, E. R. & Yuneva, M. O. Hopefully devoted to Q: targeting glutamine addiction in cancer. Br. J. Cancer 116, 1375\u20131381 (2017).","journal-title":"Br. J. Cancer"},{"key":"136_CR4","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s00005-016-0406-x","volume":"65","author":"B Zdzisi\u0144ska","year":"2017","unstructured":"Zdzisi\u0144ska, B., \u017burek, A. & Kandefer-Szersze\u0144, M. Alpha-ketoglutarate as a molecule with pleiotropic activity: well-known and novel possibilities of therapeutic use. Arch. Immunol. Ther. Exp. (Warsz.) 65, 21\u201336 (2017).","journal-title":"Arch. Immunol. Ther. Exp. (Warsz.)"},{"key":"136_CR5","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1038\/cr.2012.5","volume":"22","author":"D Anastasiou","year":"2012","unstructured":"Anastasiou, D. & Cantley, L. C. Breathless cancer cells get fat on glutamine. Cell Res. 22, 443\u2013446 (2012).","journal-title":"Cell Res."},{"key":"136_CR6","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/nature17393","volume":"532","author":"L Jiang","year":"2016","unstructured":"Jiang, L. et al. Reductive carboxylation supports redox homeostasis during anchorage-independent growth. Nature 532, 255\u2013258 (2016).","journal-title":"Nature"},{"key":"136_CR7","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.tibs.2010.07.002","volume":"36","author":"C Loenarz","year":"2011","unstructured":"Loenarz, C. & Schofield, C. J. Physiological and biochemical aspects of hydroxylations and demethylations catalyzed by human 2-oxoglutarate oxygenases. Trends Biochem. Sci. 36, 7\u201318 (2011).","journal-title":"Trends Biochem. Sci."},{"key":"136_CR8","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1016\/j.molcel.2017.06.002","volume":"66","author":"M Ivan","year":"2017","unstructured":"Ivan, M. & Kaelin, W. G. Jr. The EGLN-HIF O2-sensing system: multiple inputs and feedbacks. Mol. Cell 66, 772\u2013779 (2017).","journal-title":"Mol. Cell"},{"key":"136_CR9","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.mam.2016.01.001","volume":"47-48","author":"MC Chan","year":"2016","unstructured":"Chan, M. C., Holt-Martyn, J. P., Schofield, C. J. & Ratcliffe, P. J. Pharmacological targeting of the HIF hydroxylases: a new field in medicine development. Mol. Aspects Med. 47-48, 54\u201375 (2016).","journal-title":"Mol. Aspects Med."},{"key":"136_CR10","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/nature12040","volume":"496","author":"J Son","year":"2013","unstructured":"Son, J. et al. Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway. Nature 496, 101\u2013105 (2013).","journal-title":"Nature"},{"key":"136_CR11","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.ccell.2014.12.006","volume":"27","author":"L Jin","year":"2015","unstructured":"Jin, L. et al. Glutamate dehydrogenase 1 signals through antioxidant glutathione peroxidase 1 to regulate redox homeostasis and tumor growth. Cancer Cell 27, 257\u2013270 (2015).","journal-title":"Cancer Cell"},{"key":"136_CR12","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1016\/j.molcel.2014.01.016","volume":"53","author":"G Mari\u00f1o","year":"2014","unstructured":"Mari\u00f1o, G. et al. Regulation of autophagy by cytosolic acetyl-coenzyme A. Mol. Cell 53, 710\u2013725 (2014).","journal-title":"Mol. Cell"},{"key":"136_CR13","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1038\/nm.3294","volume":"19","author":"CM Taniguchi","year":"2013","unstructured":"Taniguchi, C. M. et al. Cross-talk between hypoxia and insulin signaling through Phd3 regulates hepatic glucose and lipid metabolism and ameliorates diabetes. Nat. Med. 19, 1325\u20131330 (2013).","journal-title":"Nat. Med."},{"key":"136_CR14","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/ng.2007.62","volume":"40","author":"J Aragon\u00e9s","year":"2008","unstructured":"Aragon\u00e9s, J. et al. Deficiency or inhibition of oxygen sensor Phd1 induces hypoxia tolerance by reprogramming basal metabolism. Nat. Genet. 40, 170\u2013180 (2008).","journal-title":"Nat. Genet."},{"key":"136_CR15","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1016\/j.cell.2016.02.006","volume":"164","author":"BA Olenchock","year":"2016","unstructured":"Olenchock, B. A. et al. EGLN1 inhibition and rerouting of \u03b1-ketoglutarate suffice for remote ischemic protection. Cell 164, 884\u2013895 (2016).","journal-title":"Cell"},{"key":"136_CR16","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1038\/nrd4422","volume":"13","author":"HK Eltzschig","year":"2014","unstructured":"Eltzschig, H. K., Bratton, D. L. & Colgan, S. P. Targeting hypoxia signalling for the treatment of ischaemic and inflammatory diseases. Nat. Rev. Drug Discov. 13, 852\u2013869 (2014).","journal-title":"Nat. Rev. Drug Discov."},{"key":"136_CR17","doi-asserted-by":"publisher","first-page":"4364","DOI":"10.1039\/c0cs00203h","volume":"40","author":"NR Rose","year":"2011","unstructured":"Rose, N. R., McDonough, M. A., King, O. N., Kawamura, A. & Schofield, C. J. Inhibition of 2-oxoglutarate dependent oxygenases. Chem. Soc. Rev. 40, 4364\u20134397 (2011).","journal-title":"Chem. Soc. Rev."},{"key":"136_CR18","doi-asserted-by":"publisher","first-page":"2652","DOI":"10.1021\/jm00092a016","volume":"35","author":"CJ Cunliffe","year":"1992","unstructured":"Cunliffe, C. J., Franklin, T. J., Hales, N. J. & Hill, G. B. Novel inhibitors of prolyl 4-hydroxylase. 3. Inhibition by the substrate analogue N-oxaloglycine and its derivatives. J. Med. Chem. 35, 2652\u20132658 (1992).","journal-title":"J. Med. Chem."},{"key":"136_CR19","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1126\/science.1059796","volume":"292","author":"P Jaakkola","year":"2001","unstructured":"Jaakkola, P. et al. Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science 292, 468\u2013472 (2001).","journal-title":"Science"},{"key":"136_CR20","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1126\/science.1059817","volume":"292","author":"M Ivan","year":"2001","unstructured":"Ivan, M. et al. HIF\u03b1 targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing. Science 292, 464\u2013468 (2001).","journal-title":"Science"},{"key":"136_CR21","doi-asserted-by":"publisher","first-page":"2852","DOI":"10.1016\/j.bmcl.2009.03.098","volume":"19","author":"S Hamada","year":"2009","unstructured":"Hamada, S. et al. Synthesis and activity of N-oxalylglycine and its derivatives as Jumonji C-domain-containing histone lysine demethylase inhibitors. Bioorg. Med. Chem. Lett. 19, 2852\u20132855 (2009).","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"136_CR22","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1042\/bj3000525","volume":"300","author":"E Baader","year":"1994","unstructured":"Baader, E., Tschank, G., Baringhaus, K. H., Burghard, H. & G\u00fcnzler, V. Inhibition of prolyl 4-hydroxylase by oxalyl amino acid derivatives in vitro, in isolated microsomes and in embryonic chicken tissues. Biochem. J. 300, 525\u2013530 (1994).","journal-title":"Biochem. J."},{"key":"136_CR23","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1038\/nrd2761","volume":"8","author":"P Fraisl","year":"2009","unstructured":"Fraisl, P., Aragon\u00e9s, J. & Carmeliet, P. Inhibition of oxygen sensors as a therapeutic strategy for ischaemic and inflammatory disease. Nat. Rev. Drug Discov. 8, 139\u2013152 (2009).","journal-title":"Nat. Rev. Drug Discov."},{"key":"136_CR24","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.ccr.2012.06.028","volume":"22","author":"R Leite de Oliveira","year":"2012","unstructured":"Leite de Oliveira, R. et al. Gene-targeting of Phd2 improves tumor response to chemotherapy and prevents side-toxicity. Cancer Cell 22, 263\u2013277 (2012).","journal-title":"Cancer Cell"},{"key":"136_CR25","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.cell.2007.01.047","volume":"129","author":"R Fukuda","year":"2007","unstructured":"Fukuda, R. et al. HIF-1 regulates cytochrome oxidase subunits to optimize efficiency of respiration in hypoxic cells. Cell 129, 111\u2013122 (2007).","journal-title":"Cell"},{"key":"136_CR26","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.cmet.2006.02.002","volume":"3","author":"JW Kim","year":"2006","unstructured":"Kim, J. W., Tchernyshyov, I., Semenza, G. L. & Dang, C. V. HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia. Cell Metab. 3, 177\u2013185 (2006).","journal-title":"Cell Metab."},{"key":"136_CR27","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.cmet.2013.11.022","volume":"19","author":"RC Sun","year":"2014","unstructured":"Sun, R. C. & Denko, N. C. Hypoxic regulation of glutamine metabolism through HIF1 and SIAH2 supports lipid synthesis that is necessary for tumor growth. Cell Metab. 19, 285\u2013292 (2014).","journal-title":"Cell Metab."},{"key":"136_CR28","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1038\/nature11005","volume":"483","author":"MJ Garnett","year":"2012","unstructured":"Garnett, M. J. et al. Systematic identification of genomic markers of drug sensitivity in cancer cells. Nature 483, 570\u2013575 (2012).","journal-title":"Nature"},{"key":"136_CR29","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.mam.2012.05.003","volume":"34","author":"AP Halestrap","year":"2013","unstructured":"Halestrap, A. P. The SLC16 gene family: structure, role and regulation in health and disease. Mol. Aspects Med. 34, 337\u2013349 (2013).","journal-title":"Mol. Aspects Med."},{"key":"136_CR30","doi-asserted-by":"publisher","first-page":"2481","DOI":"10.1016\/j.bbamcr.2016.03.013","volume":"1863","author":"J P\u00e9rez-Escuredo","year":"2016","unstructured":"P\u00e9rez-Escuredo, J. et al. Monocarboxylate transporters in the brain and in cancer. Biochim. Biophys. Acta 1863, 2481\u20132497 (2016).","journal-title":"Biochim. Biophys. Acta"},{"key":"136_CR31","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1002\/anie.197300361","volume":"12","author":"RF Hudson","year":"1973","unstructured":"Hudson, R. F. The perturbation treatment of chemical reactivity. Angew. Chem. Int. Edn Engl. 12, 36\u201356 (1973).","journal-title":"Angew. Chem. Int. Edn Engl."},{"key":"136_CR32","doi-asserted-by":"crossref","first-page":"4895","DOI":"10.1016\/S0021-9258(17)37629-9","volume":"269","author":"N Sekine","year":"1994","unstructured":"Sekine, N. et al. Low lactate dehydrogenase and high mitochondrial glycerol phosphate dehydrogenase in pancreatic beta-cells: potential role in nutrient sensing. J. Biol. Chem. 269, 4895\u20134902 (1994).","journal-title":"J. Biol. Chem."},{"key":"136_CR33","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1042\/bj3410529","volume":"341","author":"S Br\u00f6er","year":"1999","unstructured":"Br\u00f6er, S. et al. Characterization of the high-affinity monocarboxylate transporter MCT2 in Xenopus laevis oocytes. Biochem. J. 341, 529\u2013535 (1999).","journal-title":"Biochem. J."},{"key":"136_CR34","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1038\/msb.2013.65","volume":"9","author":"J Fan","year":"2013","unstructured":"Fan, J. et al. Glutamine-driven oxidative phosphorylation is a major ATP source in transformed mammalian cells in both normoxia and hypoxia. Mol. Syst. Biol. 9, 712 (2013).","journal-title":"Mol. Syst. Biol."},{"key":"136_CR35","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1016\/j.bbabio.2015.06.016","volume":"1847","author":"AV Zhdanov","year":"2015","unstructured":"Zhdanov, A. V., Okkelman, I. A., Collins, F. W., Melgar, S. & Papkovsky, D. B. A novel effect of DMOG on cell metabolism: direct inhibition of mitochondrial function precedes HIF target gene expression. Biochim. Biophys. Acta 1847, 1254\u20131266 (2015).","journal-title":"Biochim. Biophys. Acta"},{"key":"136_CR36","doi-asserted-by":"publisher","first-page":"4563","DOI":"10.1021\/bi400514k","volume":"52","author":"AR Rendina","year":"2013","unstructured":"Rendina, A. R. et al. Mutant IDH1 enhances the production of 2-hydroxyglutarate due to its kinetic mechanism. Biochemistry 52, 4563\u20134577 (2013).","journal-title":"Biochemistry"},{"key":"136_CR37","doi-asserted-by":"publisher","first-page":"5957","DOI":"10.1111\/febs.12268","volume":"280","author":"DB Kell","year":"2013","unstructured":"Kell, D. B. Finding novel pharmaceuticals in the systems biology era using multiple effective drug targets, phenotypic screening and knowledge of transporters: where drug discovery went wrong and how to fix it. FEBS J. 280, 5957\u20135980 (2013).","journal-title":"FEBS J."},{"key":"136_CR38","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1097\/FPC.0b013e3283559b22","volume":"22","author":"L Gong","year":"2012","unstructured":"Gong, L., Goswami, S., Giacomini, K. M., Altman, R. B. & Klein, T. E. Metformin pathways: pharmacokinetics and pharmacodynamics. Pharmacogenet. Genomics 22, 820\u2013827 (2012).","journal-title":"Pharmacogenet. Genomics"},{"key":"136_CR39","doi-asserted-by":"publisher","first-page":"3037","DOI":"10.1038\/onc.2015.360","volume":"35","author":"L Gan","year":"2016","unstructured":"Gan, L. et al. Metabolic targeting of oncogene MYC by selective activation of the proton-coupled monocarboxylate family of transporters. Oncogene 35, 3037\u20133048 (2016).","journal-title":"Oncogene"},{"key":"136_CR40","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1002\/pros.22620","volume":"73","author":"N P\u00e9rtega-Gomes","year":"2013","unstructured":"P\u00e9rtega-Gomes, N. et al. Monocarboxylate transporter 2 (MCT2) as putative biomarker in prostate cancer. Prostate 73, 763\u2013769 (2013).","journal-title":"Prostate"},{"key":"136_CR41","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/j.celrep.2016.09.042","volume":"17","author":"S Christen","year":"2016","unstructured":"Christen, S. et al. Breast cancer-derived lung metastases show increased pyruvate carboxylase-dependent anaplerosis. Cell Rep. 17, 837\u2013848 (2016).","journal-title":"Cell Rep."},{"key":"136_CR42","first-page":"930","volume":"45","author":"N Avril","year":"2004","unstructured":"Avril, N. GLUT1 expression in tissue and (18)F-FDG uptake. J. Nucl. Med. 45, 930\u2013932 (2004).","journal-title":"J. Nucl. Med."},{"key":"136_CR43","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1016\/j.chembiol.2017.08.016","volume":"24","author":"A Kulkarni","year":"2017","unstructured":"Kulkarni, A. et al. Glucose metabolism and oxygen availability govern reactivation of the latent human retrovirus HTLV-1. Cell Chem. Biol. 24, 1377\u20131387.e1373 (2017).","journal-title":"Cell Chem. Biol."},{"key":"136_CR44","doi-asserted-by":"publisher","first-page":"2703","DOI":"10.1093\/jn\/133.9.2703","volume":"133","author":"RL Daberkow","year":"2003","unstructured":"Daberkow, R. L., White, B. R., Cederberg, R. A., Griffin, J. B. & Zempleni, J. Monocarboxylate transporter 1 mediates biotin uptake in human peripheral blood mononuclear cells. J. Nutr. 133, 2703\u20132706 (2003).","journal-title":"J. Nutr."},{"key":"136_CR45","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1038\/nrd2199","volume":"5","author":"JP Overington","year":"2006","unstructured":"Overington, J. P., Al-Lazikani, B. & Hopkins, A. L. How many drug targets are there? Nat. Rev. Drug Discov. 5, 993\u2013996 (2006).","journal-title":"Nat. Rev. Drug Discov."},{"key":"136_CR46","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.sbi.2006.01.013","volume":"16","author":"AL Hopkins","year":"2006","unstructured":"Hopkins, A. L., Mason, J. S. & Overington, J. P. Can we rationally design promiscuous drugs? Curr. Opin. Struct. Biol. 16, 127\u2013136 (2006).","journal-title":"Curr. Opin. Struct. Biol."},{"key":"136_CR47","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1038\/nrc2787","volume":"10","author":"ZA Knight","year":"2010","unstructured":"Knight, Z. A., Lin, H. & Shokat, K. M. Targeting the cancer kinome through polypharmacology. Nat. Rev. Cancer 10, 130\u2013137 (2010).","journal-title":"Nat. Rev. Cancer"},{"key":"136_CR48","doi-asserted-by":"publisher","first-page":"2953","DOI":"10.15252\/embj.201591437","volume":"34","author":"J Zhang","year":"2015","unstructured":"Zhang, J. et al. EglN2 associates with the NRF1-PGC1\u03b1 complex and controls mitochondrial function in breast cancer. EMBO J. 34, 2953\u20132970 (2015).","journal-title":"EMBO J."},{"key":"136_CR49","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.cmet.2006.01.012","volume":"3","author":"I Papandreou","year":"2006","unstructured":"Papandreou, I., Cairns, R. A., Fontana, L., Lim, A. L. & Denko, N. C. HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption. Cell Metab. 3, 187\u2013197 (2006).","journal-title":"Cell Metab."},{"key":"136_CR50","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.1038\/nprot.2013.143","volume":"8","author":"FA Ran","year":"2013","unstructured":"Ran, F. A. et al. Genome engineering using the CRISPR-Cas9 system. Nat. Protoc. 8, 2281\u20132308 (2013).","journal-title":"Nat. Protoc."},{"key":"136_CR51","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1016\/j.chembiol.2004.05.011","volume":"11","author":"SR Starck","year":"2004","unstructured":"Starck, S. R., Green, H. M., Alberola-Ila, J. & Roberts, R. W. A general approach to detect protein expression in vivo using fluorescent puromycin conjugates. Chem. Biol. 11, 999\u20131008 (2004).","journal-title":"Chem. Biol."},{"key":"136_CR52","doi-asserted-by":"publisher","first-page":"14431","DOI":"10.1021\/bi048817i","volume":"43","author":"A Allen","year":"2004","unstructured":"Allen, A., Kwagh, J., Fang, J., Stanley, C. A. & Smith, T. J. Evolution of glutamate dehydrogenase regulation of insulin homeostasis is an example of molecular exaptation. Biochemistry 43, 14431\u201314443 (2004).","journal-title":"Biochemistry"},{"key":"136_CR53","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1038\/nprot.2006.478","volume":"2","author":"C Frezza","year":"2007","unstructured":"Frezza, C., Cipolat, S. & Scorrano, L. Organelle isolation: functional mitochondria from mouse liver, muscle and cultured fibroblasts. Nat. Protoc. 2, 287\u2013295 (2007).","journal-title":"Nat. Protoc."},{"key":"136_CR54","doi-asserted-by":"publisher","first-page":"1994","DOI":"10.1021\/ac2030738","volume":"84","author":"T Zhang","year":"2012","unstructured":"Zhang, T., Creek, D. J., Barrett, M. P., Blackburn, G. & Watson, D. G. Evaluation of coupling reversed phase, aqueous normal phase, and hydrophilic interaction liquid chromatography with Orbitrap mass spectrometry for metabolomic studies of human urine. Anal. Chem. 84, 1994\u20132001 (2012).","journal-title":"Anal. Chem."},{"key":"136_CR55","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/BF00175254","volume":"4","author":"J Schleucher","year":"1994","unstructured":"Schleucher, J. et al. A general enhancement scheme in heteronuclear multidimensional NMR employing pulsed field gradients. J. Biomol. NMR 4, 301\u2013306 (1994).","journal-title":"J. Biomol. NMR"},{"key":"136_CR56","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1021\/ja00268a061","volume":"108","author":"A Bax","year":"1986","unstructured":"Bax, A. & Summers, M. F. H-1 and C-13 assignments from sensitivity-enhanced detection of heteronuclear multiple-bond connectivity by 2D multiple quantum NMR. J. Am. Chem. Soc. 108, 2093\u20132094 (1986).","journal-title":"J. Am. Chem. Soc."},{"key":"136_CR57","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1006\/jmra.1995.1047","volume":"112","author":"TL Hwang","year":"1995","unstructured":"Hwang, T. L. & Shaka, A. J. Water suppression that works: excitation sculpting using arbitrary wave-forms and pulsed-field gradients. J. Magn. Reson. 112, 275\u2013279 (1995).","journal-title":"J. Magn. Reson."},{"key":"136_CR58","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1023\/A:1013302231549","volume":"21","author":"C Dalvit","year":"2001","unstructured":"Dalvit, C., Fogliatto, G., Stewart, A., Veronesi, M. & Stockman, B. WaterLOGSY as a method for primary NMR screening: practical aspects and range of applicability. J. Biomol. NMR 21, 349\u2013359 (2001).","journal-title":"J. Biomol. NMR"},{"key":"136_CR59","doi-asserted-by":"publisher","first-page":"2378","DOI":"10.1021\/bi00432a006","volume":"28","author":"RE London","year":"1989","unstructured":"London, R. E. & Gabel, S. A. Determination of membrane potential and cell volume by 19F NMR using trifluoroacetate and trifluoroacetamide probes. Biochemistry 28, 2378\u20132382 (1989).","journal-title":"Biochemistry"}],"updated-by":[{"DOI":"10.1038\/s41589-019-0409-0","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2019,10,23]],"date-time":"2019-10-23T00:00:00Z","timestamp":1571788800000}}],"container-title":["Nature Chemical Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41589-018-0136-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41589-018-0136-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41589-018-0136-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T22:26:22Z","timestamp":1684621582000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41589-018-0136-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,8]]},"references-count":59,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["136"],"URL":"https:\/\/doi.org\/10.1038\/s41589-018-0136-y","relation":{"correction":[{"id-type":"doi","id":"10.1038\/s41589-019-0409-0","asserted-by":"object"}]},"ISSN":["1552-4450","1552-4469"],"issn-type":[{"value":"1552-4450","type":"print"},{"value":"1552-4469","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,8]]},"assertion":[{"value":"4 September 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2019","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"An amendment to this paper has been published and can be accessed via a link at the top of the paper.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}